Warwick, RI, United States of America

Andrew T Maioli



Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Worcester, MA (US) (2007 - 2009)
  • Warwick, RI (US) (2006 - 2011)

Company Filing History:


Years Active: 2006-2011

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Andrew T. Maioli: Pioneering Antiallergic Therapies

Introduction

Andrew T. Maioli, a prominent inventor based in Warwick, RI, has significantly contributed to the field of pharmacology through his innovative patents. With a total of four patents to his name, Maioli’s work is characterized by a focus on developing therapeutically active metabolites with improved efficacy and reduced side effects.

Latest Patents

Maioli's latest patents include groundbreaking research on optically active isomers of ketotifen, specifically racemic norketotifen, racemic 10-hydroxy-ketotifen, and racemic 10-hydroxy-nor-ketotifen. These compounds have been identified as having antiallergic and anti-inflammatory effects while lacking the severe dose-limiting sedative side effects associated with traditional Ketotifen. This advancement represents a significant step forward in allergy treatment, promising better patient outcomes without compromising safety.

Career Highlights

Andrew T. Maioli has built his career at Bridge Pharma Inc., where he plays an integral role in the research and development of new pharmaceutical solutions. His dedication to enhancing therapeutic profiles of existing medications showcases his commitment to improving patient care through innovative science.

Collaborations

Throughout his career, Maioli has collaborated with esteemed colleagues, including A.K. Gunnar Aberg and George Edward Wright. These partnerships reflect the collaborative spirit prevalent within the pharmaceutical research community, driving forward the collective goal of innovation in healthcare.

Conclusion

In conclusion, Andrew T. Maioli’s contributions to patent innovations, particularly in the development of safer and more effective antiallergic therapies, underscore the importance of research in improving medicinal outcomes. His work at Bridge Pharma Inc. exemplifies the impact that dedicated inventors can have on the medical field, paving the way for future developments in pharmacological therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…